FTC Targets Disclosures, “Up To” And “Doctor Recommended” Claims

“A lot of research casts doubt on the effectiveness of disclosures,” says FTC official Richard Cleland. FTC will also zero in on “up-to,” “doctor recommended,” business-to-business, immunity and weight loss claims.

Advertisers’ “wholesale failure” to clearly and conspicuously communicate disclosures and disclaimers to consumers spurs Federal Trade Commission scrutiny, says Richard Cleland, assistant director of FTC’s Division of Advertising Practices.

FTC will increase its scrutiny of whether disclosures and disclaimers in advertising are clear and conspicuous and easy for consumers...

More from United States

More from North America